|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-1-21
|
|
pubmed:abstractText |
We report the first case of cutaneous leishmaniasis in a patient treated with infliximab. The species was Leishmania infantum, agent of both cutaneous leishmaniasis and visceral leishmaniasis. Cutaneous leishmaniasis occurred after the 9th infusion of infliximab in a patient who was suffering from ankylosing spondylitis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9832
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2009 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
220
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
63-5
|
|
pubmed:meshHeading |
pubmed-meshheading:19907139-Antibodies, Monoclonal,
pubmed-meshheading:19907139-Antiprotozoal Agents,
pubmed-meshheading:19907139-Antirheumatic Agents,
pubmed-meshheading:19907139-Humans,
pubmed-meshheading:19907139-Leishmania infantum,
pubmed-meshheading:19907139-Leishmaniasis, Cutaneous,
pubmed-meshheading:19907139-Male,
pubmed-meshheading:19907139-Meglumine,
pubmed-meshheading:19907139-Middle Aged,
pubmed-meshheading:19907139-Organometallic Compounds,
pubmed-meshheading:19907139-Spondylitis, Ankylosing,
pubmed-meshheading:19907139-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Localized Cutaneous Leishmaniasis due to Leishmania infantum in a Patient Treated with Infliximab.
|
|
pubmed:affiliation |
Service de Médecine Interne A, Centre Hospitalier Universitaire, Montpellier, France. sophie78@netcourrier.com
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
